cetuximab,encorafenib,binimetinib,fruquintinib
pfizer,hutchmed,eli lilly,array biopharma
['fresco2', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'beacon']
great discussion of #fresco2 trial and acquired resistance in the #beacon study in #mcrc by during #esmo22 
(Young) Medical oncologist